[1] 李亭亭, 刘芳, 王方. 年龄相关性黄斑变性与阿尔茨海默病的相关性[J]. 眼科新进展, 2017, 37(12):1189-1192. [2] 李彩云. 阿尔茨海默病的中医药治疗研究进展[J]. 临床合理用药杂志, 2020, 13(2):172-174. [3] 刘莹, 刘霞, 崔平, 等. 中国老年人阿尔茨海默病患病率及发展趋势研究[J]. 中国卫生统计, 2022, 39(6):878-881, 884. [4] SILVERBERG N, ELLIOTT C, RYAN L, et al.NIA commentary on the NIA-AA research framework: towards a biological definition of Alzheimer’s disease[J]. Alzheimers Dement, 2018, 14(4):576-578. [5] VANWIJNGAARDEN P, HADOUX X, ALWAN M, et al. Emerging ocular biomarkers of Alzheimer disease[J]. Clin Exp Ophthalmol, 2017, 45(1): 54-61. [6] 鲍静, 周琼. 早期阿尔茨海默病患者黄斑区视网膜血管密度及厚度变化:基于OCTA的测量[J]. 眼科新进展, 2020, 40(6):547-550. [7] ERSKINE D, TAYLOR J P, FIRBANK M J, et al. Changes to the lateral geniculate nucleus in Alzheimer’s disease but not dementia with Lewy bodies[J]. Neuropathol Appl Neurobiol, 2016, 42(4): 366-376. [8] MURCIA-BELMONTE V, ERSKINE L. Wiring the binocular visual pathways[J]. Int J Mol Sci, 2019, 20(13):E3282. [9] 池滢, 王荫华, 杨柳. 阿尔茨海默病视网膜神经纤维丢失的临床观察[J]. 中华眼科杂志, 2010, 46(2): 134-139. [10] GE Y J, XU W, OU Y N, et al. Retinal biomarkers in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis[J]. Ageing Res Rev, 2021, 69: 101361. [11] RATCHFORD J N, QUIGG M E, CONGER A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies[J]. Neurology, 2009, 73(4): 302-308. [12] ISERI P K, ALTINAŞ O, TOKAY T, et al. Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease[J]. J Neuroophthalmol, 2006, 26(1):18-24. |